More than 360 firms reported lobbying on the 340B program between July 1 and Sept. 30.
340B Lobbying Activity Did Not Slow Down in Q3, Federal Filings Suggest
The 340B drug discount program continued to be a hot topic for lobbyists in the third quarter of 2024, keeping [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.